GeneDx Holdings (WGS) Other Non-Current Liabilities (2020 - 2026)

GeneDx Holdings (WGS) has reported Other Non-Current Liabilities for 7 consecutive years, with $71000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 97.83% year-over-year to $71000.0 in Q2 2026; TTM through Jun 2026 was $71000.0, a 97.83% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, down 70.27% from the prior year.
• Other Non-Current Liabilities was $71000.0 for Q2 2026 at GeneDx Holdings, roughly flat from $71000.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $24.0 million in Q4 2022 and troughed at $71000.0 in Q1 2026.
• A 5-year average of $11.4 million and a median of $10.0 million in 2022 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities surged 550.32% in 2023 and slumped 98.93% in 2026, its largest moves.
• Over 5 years, Other Non-Current Liabilities stood at $24.0 million in 2022, then sank by 38.65% to $14.7 million in 2023, then tumbled by 62.54% to $5.5 million in 2024, then plunged by 70.27% to $1.6 million in 2025, then tumbled by 95.67% to $71000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $71000.0 (Q2 2026), $71000.0 (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.